EMILIE HUNGERFORD: Open Payments
NPI 1881243756 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 46 payments from 13 companies in 2025. Trend: 2023 $187 · 2024 $836 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $308 |
| Astellas Pharma US Inc | 6 | $132 |
| Lilly USA, LLC | 4 | $77 |
| ABBVIE INC. | 3 | $65 |
| PFIZER INC. | 4 | $60 |
| Corium, LLC | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Exact Sciences Corporation | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| RGH Enterprises LLC | 1 | $22 |
Products named: Wegovy, Veozah, MOUNJARO, NURTEC ODT, Azstarys, VOQUEZNA, Ozempic, AVYCAZ.
Industry payments across IN — which companies pay providers there.
